Table 3

Plasma catecholamine concentrations during positron emission tomographic (PET) studies in diabetic and non-diabetic study patients

Type 1 diabeticNon-diabetic
FastingDuring clampFastingDuring clamp
*p<0.05 v non-diabetic; †p<0.05 v fasting; ‡p<0.05 v dx−.
Plasma adrenaline (nmol/l)
    dx−0.24 (0.03)*0.39 (0.07)†0.15 (0.03)0.27 (0.02)†
    dx+0.14 (0.03)‡0.24 (0.05)†0.12 (0.02)0.23 (0.03)†
Plasma noradrenaline (nmol/l)
    dx−1.42 (0.15)2.00 (0.29)†1.41 (0.17)2.01 (0.17)†
    dx+1.17 (0.21)1.97 (0.26)*†1.03 (0.11)‡1.23 (0.09)‡